The AACR Special Conference in Cancer Research: Advances in the Pathogenesis and Immune Therapies of Liver Cancer will take place from December 6–8, 2026, at the Hyatt Regency Austin in Austin, Texas, USA.

Organized by the American Association for Cancer Research (AACR), the conference will bring together basic scientists, physician-scientists, and industry professionals to discuss advances in liver cancer biology and treatment.

The program will cover the molecular pathogenesis and risk factors of hepatocellular carcinoma, immunotherapy across early-, intermediate-, and advanced-stage HCC, cholangiocarcinoma, tumor microenvironment, immune modulation, microbiome, predictive biomarkers, liquid biopsy, clinical trial design, and emerging therapeutic combinations. Sessions will also address health disparities, pediatric liver tumors, and the patient advocacy perspective.